Anti-TNF antibodies linked to malignancy/serious infection

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1540, 2006-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal anti-TNF antibodies may increase risk of herpes zoster

By  

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Utility of Measuring Serum Concentrations of Anti-TNF Agents and Anti-Drug Antibodies in Inflammatory Bowel Disease

By  

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 594-598

Bentham Science Publishers

Access to resources Recommend Favorite

Measurement of Anti-TNF Agents and Anti-Drug Antibodies Serum Levels in Patients with Inflammatory Bowel Disease

By  

Current Drug Metabolism, Vol. 15, Iss. 9, 2014-11 ,pp. : 875-881

Bentham Science Publishers

Access to resources Recommend Favorite

TNF antagonists increase risk of serious infection

By  

Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Anti-TNF Antibodies in Inflammatory Bowel Disease: Do We Finally Know How it Works?

By  

Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. : 1421-1432

Bentham Science Publishers

Access to resources Recommend Favorite